ESR1 and breast cancer: ESR-mediated signalling was identified as the pathway whose genes are overcharged by a higher epimutation score due to hypomethylation of the TSS1500 gene region (corresponding at least in part to the promoter region) in ER-positive BC vs. ER-negative BC.